You are here

Article info

Article menu
Immune cell therapies and immune cell engineering
Original research
Efficient CAR T cell targeting of the CA125 extracellular repeat domain of MUC16

Authors

  • Nicholas P Casey Translational Research Unit, Section of Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway PubMed articlesGoogle scholar articles
  • Katrin Kleinmanns Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Bergen, Norway PubMed articlesGoogle scholar articles
  • Christopher Forcados Translational Research Unit, Section of Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway PubMed articlesGoogle scholar articles
  • Pascal F Gelebart Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Bergen, Norway PubMed articlesGoogle scholar articles
  • Sandy Joaquina Translational Research Unit, Section of Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway PubMed articlesGoogle scholar articles
  • Martine Lode Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Bergen, Norway PubMed articlesGoogle scholar articles
  • Emmanuelle Benard Translational Research Unit, Section of Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway PubMed articlesGoogle scholar articles
  • Fatemeh Kaveh Translational Research Unit, Section of Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway PubMed articlesGoogle scholar articles
  • Benjamin Caulier Translational Research Unit, Section of Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, NorwayDepartment of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, NorwayCenter for Cancer Cell Reprogramming (CanCell), Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway PubMed articlesGoogle scholar articles
  • Christiane Helgestad Gjerde Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Bergen, NorwayDepartment of Obstetrics and Gynecology, Haukeland University Hospital, Bergen, Norway PubMed articlesGoogle scholar articles
  • Elvira García de Jalón Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Bergen, Norway PubMed articlesGoogle scholar articles
  • David J Warren Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway PubMed articlesGoogle scholar articles
  • Kristina Lindemann Department of Gynecologic Oncology, Oslo University Hospital, Oslo, NorwayInstitute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway PubMed articlesGoogle scholar articles
  • Erik Rokkones Department of Gynecologic Oncology, Oslo University Hospital, Oslo, Norway PubMed articlesGoogle scholar articles
  • Ben Davidson Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, NorwayDepartment of Pathology, Division of Laboratory Medicine, Oslo University Hospital, Oslo, Norway PubMed articlesGoogle scholar articles
  • Marit Renee Myhre Translational Research Unit, Section of Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway PubMed articlesGoogle scholar articles
  • Gunnar Kvalheim Translational Research Unit, Section of Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway PubMed articlesGoogle scholar articles
  • Line Bjørge Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Bergen, NorwayDepartment of Obstetrics and Gynecology, Haukeland University Hospital, Bergen, Norway PubMed articlesGoogle scholar articles
  • Emmet McCormack Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Bergen, NorwayCentre for Pharmacy, Department of Clinical Science, University of Bergen, Bergen, NorwayDepartment of Internal Medicine, Hematology Section, Haukeland University Hospital, Bergen, Norway PubMed articlesGoogle scholar articles
  • Else Marit Inderberg Translational Research Unit, Section of Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway PubMed articlesGoogle scholar articles
  • Sébastien Wälchli Translational Research Unit, Section of Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway PubMed articlesGoogle scholar articles

Citation

Casey NP, Kleinmanns K, Forcados C, et al
Efficient CAR T cell targeting of the CA125 extracellular repeat domain of MUC16
Journal for ImmunoTherapy of Cancer 2024;12:e008179. doi: 10.1136/jitc-2023-008179
Online issue publication 
April 11, 2024

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.